Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023415Phase 4Recruiting
Phase 4, open-label trial of ketorolac, ibuprofen and acetaminophen in hip dysplasia (DDH) (3 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Pain score, Sedation score and 3 more. Started Jan 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023415.